LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

COVID-19: Pitfalls in Offering Research Participation as Therapy in Clinical Settings

Photo from archive.org

Following an outbreak of a novel Coronavirus (COVID-19) in Wuhan City, Hubei Province of China, rapid community, regional and international spread has occurred with exponential growth in cases and deaths… Click to show full abstract

Following an outbreak of a novel Coronavirus (COVID-19) in Wuhan City, Hubei Province of China, rapid community, regional and international spread has occurred with exponential growth in cases and deaths On 30 January 2020, the Director-General (DG) of the WHO declared the COVID-19 outbreak a public health emergency of international concern (PHEIC) under the International Health Regulations (IHR) (2005) The first case in the Americas was confirmed in the USA on 20 January 2020, followed by Brazil on 26 February 2020 Since then, COVID-19 has spread to all 54 countries and territories in the Americas Situation in numbers in the Americas as of 03 August (15:00): 9,741,727 confirmed cases;365,334 deaths;54 countries / areas / territories counted for epidemiological purposes

Keywords: covid pitfalls; offering research; therapy clinical; participation therapy; pitfalls offering; research participation

Journal Title: Journal of General Internal Medicine
Year Published: 2020

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.